Home / Publication / Characterization of the Transmembrane Transport and Absolute Bioavailability of the HCV Protease Inhibitor Danoprevir

刊物

Characterization of the Transmembrane Transport and Absolute Bioavailability of the HCV Protease Inhibitor Danoprevir

Author(s): Barbara Brennan, Agnes Poirier, Sebastian Moreira, Peter Morcos, Petra Goelzer, Renee Portmann, Jiney Asthappan, Christoph Funk, Patrick Smith

Year: 2014 年 12 月 1 日

Calculating AUC (Linear and Log-linear)

博客

Accumulation: What It Means and How to Calculate It

博客

Blending Science & Impact in Drug Development: Felix Boakye-Agyeman, Vice President of the QSS Division at Certara

视频

Bridging Strategy & Execution: Sophia Fong’s Approach to Drug Development

视频

沪ICP备2022021526号

Powered by Translations.com GlobalLink Web Software

Characterization of the Transmembrane Transport and Absolute Bioavailability of the HCV Protease Inhibitor Danoprevir

Characterization of the Transmembrane Transport and Absolute Bioavailability of the HCV Protease Inhibitor Danoprevir

Calculating AUC (Linear and Log-linear)

Accumulation: What It Means and How to Calculate It

Blending Science & Impact in Drug Development: Felix Boakye-Agyeman, Vice President of the QSS Division at Certara

Bridging Strategy & Execution: Sophia Fong’s Approach to Drug Development

订阅时事通讯

快捷链接

解决方案

联系我们